---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-013899"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T03:20:05.853515+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma Q3 revenue down 16% YoY; net income falls to $16K from $0.8M

## Summary
- Quarterly revenue $13.1M, down 16.2% from $15.6M in prior year.
- Operating income $44K vs $1.0M; net income $16K ($0.00 EPS) vs $0.8M ($0.03 EPS).
- Nine-month net loss $74K vs net income $2.3M in prior year.
- Two largest customers fell from 91% to 88% of revenue; overstocking during pandemic cited as cause.

## SEC filing metadata
- accession: 0001437749-23-013899
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774923013899/0001437749-23-013899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774923013899/inbp20230509_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-013899
- JSON: https://secwatch.observer/filing/0001437749-23-013899.json
- Plain text: https://secwatch.observer/filing/0001437749-23-013899.txt

## Key facts
- Earnings Releases
  INTEGRATED BIOPHARMA INC reported financial results for the three and nine months ended March 31, 2023.
  - Period: the three and nine months ended March 31, 2023
  - Result: reported results
  source text: On May 11, 2023, Integrated Biopharma, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774923013899/0001437749-23-013899-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.